期刊文献+

干细胞治疗2型糖尿病及其并发症的可行性 被引量:2

Stem cells therapy for treatment of diabetic mellitus and complications
下载PDF
导出
摘要 背景:2型糖尿病药物治疗有效,但病情仍不断进展。近年来,干细胞尤其间充质干细胞治疗2型糖尿病及其并发症倍受关注,并在基础及临床开展了一系列研究。目的:总结分析近年来干细胞在治疗2型糖尿病及其并发症方面取得的进展,为今后的临床研究提供方向。方法:由第一作者应用计算机检索PubMed数据库1981年1月至2012年1月有关干细胞治疗2型糖尿病及并发症的相关文章,英文检索词为"diabetic mellitus,stem cells,mesenchymal stem cells,complication,therapy"。排除重复性研究,共保留57篇文献进行综述。结果与结论:干细胞通过多种途径促进胰岛β细胞的存活和再生,减少凋亡,达到治疗2型糖尿病的目的。而且还通过多向分化及释放旁分泌因子的方式治疗糖尿病心肌病、神经病变等并发症。其中成体干细胞,尤其是间充质干细胞由于取材方便、免疫原性低、无伦理争议等优点,更适合作为种子细胞,成为目前及今后治疗2型糖尿病及其并发症的研究重点。 BACKGROUND: Type 2 diabetes mellitus can be effectively treated by drugs, but it still continues to progress. Recently stem cells in particular mesenchymal stern cells for treatment of type 2 diabetes mellitus have been paid increasing attention, and a series of basic and clinical studies have been made. OBJECTIVE: To summarize and analyze the research progress in stem cells therapy for treatment of type 2 diabetes mellitus and complications, which provide direction for future clinical studies. METHODS: A computer-based online retrieval was performed by the first author in PubMed database for searching the papers describing stem cells therapy for treatment of type 2 diabetes mellitus and the complications published between January 1981 and January 2012 in English with the key word "diabetic mellitus, stem cells, mesenchymal stern cells, complication, therapy". Repetitive studies were excluded and 57 papers were included in the final analysis. RESULTS AND CONCLUSION: Stem cells can be used to treat type 2 diabetes mellitus by promoting pancreatic β-ce survival and regeneration and reducing apoptosis. Furthermore, stem cells can also be used to treat the complications of type 2 diabetes metiitus including diabetic cardiomyopathy and neurepathy. Adult stern celts, in particular mesenchymal stem cells, are more suitable for use as seed cells because of convenient harvest, low immunogenicity and no ethical disputes, and become the focus for current and future studies regarding treatment of type 2 diabetes mellitus and complications.
出处 《中国组织工程研究》 CAS CSCD 2012年第49期9276-9282,共7页 Chinese Journal of Tissue Engineering Research
  • 相关文献

参考文献2

二级参考文献11

  • 1Wei Jiang,Yan Shi,Dongxin Zhao,Song Chen,Jun Yong,Jing Zhang,Tingting Qing,Xiaoning Sun,Peng Zhang,Mingxiao Ding,Dongsheng Li,Hongkui Deng.In vitro derivation of functional insulin-producing cells from human embryonic stem cells[J].Cell Research,2007,17(4):333-344. 被引量:38
  • 2UK Prospective Diabetes Study Group.Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)[].The Lancet.1998
  • 3Shapiro AM,,Lakey JR,Ryan EA,Korbutt GS,Toth E,Warnock GL, et al.Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen[].The New England Journal of Medicine.2000
  • 4Gunnarsson R,Klintmalm G,Lundgren G,Wilczek H,Ostman J,Groth CG.Deterioration in glucose metabolism in pancreatic transplant recipients given cyclosporine[].The Lancet.1983
  • 5Assady S,Maor G,Amit M,Itskovitz-Eldor J,Skorecki KL,Tzukerman M.Insulin production by human embryonic stem cells[].Diabetes.2001
  • 6Yang L,Li S,Hatch H,Ahrens K,Cornelius JG,Petersen BE.Peck AB: In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine homone-producing cells[].Proceedings of the National Academy of Sciences of the United States of America.2002
  • 7Bonner-Weir S,Taneja M,Weir GC,Tatarkiewicz K,Song KH,Sharma A,et al.In vitro cultivation of human islets from expanded ductal tissue[].Proceedings of the National Academy of Sciences of the United States of America.2000
  • 8Ramiya VK,Maraist M,Arfors KE,Schatz DA,Peck AB,Cornelius JG.Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells[].Nature Medicine.2000
  • 9Timper K,Seboek D,Eberhardt M,Linscheid P,Christ-Crain M,Keller U,Müller B,Zulewski H.Human adipose tissue-derived mesenchymal stem cells differenti- ate into insulin,somatostatin,and glucagon expressing cells[].Biochemical and Biophysical Research Communica- tions.2006
  • 10Pittenger MF,Mackay AM,Beck SC,Jaiswal RK,Douglas R,Mosca JD et al.Multilineage potential of adult human mesenchymal stem cells[].Science.1999

共引文献141

同被引文献10

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部